The study was designed as a randomized controlled open trial, and was conducted at the Department of Molecular Gastroenterology and Hepatology at Kyoto Prefectural University of Medicine, Japan.

Changes Clinical Practice Endoscopic mucosal resection (EMR) is a welcome advance as a low-risk alternative for the management of early colonic mucosal lesions. In this multicenter, prospective ...

Both endoscopic submucosal dissection and endoscopic mucosal resection were found to be highly effective for endoscopic resection of early Barrett’s esophagus neoplasia and compared similarly ...

CHARLOTTE, N.C. — Distal cap-assisted endoscopic mucosal resection is safe and effective for managing non-lifting and fibrotic colorectal polyps, according to a multicenter study presented at ACG 2022 ...

Boston Scientific Corporation has announced the launch of the Captivator EMR Device for Endoscopic Mucosal Resection (EMR). The device is a minimally invasive alternative to an esophagectomy, a ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Gastric cancer, also known as stomach cancer, is a highly prevalent and aggressive form of the disease that increases the risk of cardiovascular diseases. Depending on the stage of the cancer, ...

A phase I dose escalation trial of CP-675206 (tremelimumab) in combination with gemcitabine in patients with chemotherapy-naive metastatic pancreatic cancer. A phase I study, with expanded cohort, of ...

The evidence on efficacy of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) of non-ampullary duodenal lesions is limited in quantity and there are safety concerns ...